1. Recent Advances in Natural Products with Anti-Leukemia and Anti- Lymphoma Activities
   Zhi-Gang Sun et al, 2024, Mini-Reviews in Medicinal Chemistry CrossRef
2. NSUN2 alleviates doxorubicin-induced myocardial injury through Nrf2-mediated antioxidant stress
   Yi Wang et al, 2023, Cell Death Discovery CrossRef
3. Effect of pre-low-dose irradiation on anticancer activities of gallic acid in leukemic K562 and K562/Dox cells: cell viability and cellular energetic state studies
   Khin TheNu Aye et al, 2022, Medical Oncology CrossRef
4. Low-dose radiation-induced cell death in doxorubicin-sensitive leukemic K562 and resistant leukemic K562/Dox cancer cells associated with ferroptosis induction
   Sakornniya Wattanapongpitak et al, 2023, Toxicology and Environmental Health Sciences CrossRef
5. Modulation of p-glycoprotein-mediated efflux pirarubicin in living multidrug-resistant K562/Dox cell lines by 4-hydroxybenzoic acid and 4-hydroxy-3-methoxybenzoic acid via impairment of the cellular energetic state
   Ohnmar Myint et al, 2022, Toxicology Reports CrossRef
6. Study on Sgc8 aptamer-mediated nucleic acid nanomaterial-doxorubicin complex for tumor targeted therapy
   Xuemei Hu et al, 2023, European Journal of Pharmaceutics and Biopharmaceutics CrossRef
7. An update on the potential mechanism of gallic acid as an antibacterial and anticancer agent
   Saeedeh Keyvani‐Ghamsari et al, 2023, Food Science & Nutrition CrossRef